Effect of Different Corticosteroid Regimens on the Outcome of Severe COVID-19-Related Acute Respiratory Failure. A Retrospective Analysis
Background: Systemic corticosteroids are associated with reduced mortality in COVID-19-related acute respiratory failure; however, the type and dose has not yet been established. Objectives: To compare the outcomes of dexamethasone vs. methylprednisolone, along with the effects of rescue, short-term...
Enregistré dans:
Auteurs principaux: | Michele Umbrello, Paolo Formenti, Stefano Nespoli, Eleonora Pisano, Cecilia Bonino, Stefano Muttini |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/8aba2da3dac94ea3ae82c0e79a04ea8e |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Fragility Index and Fragility Quotient in Randomized Controlled Trials on Corticosteroids in ARDS Due to COVID-19 and Non-COVID-19 Etiology
par: Maria Vargas, et autres
Publié: (2021) -
Dismal Survival in COVID-19 Patients Requiring ECMO as Rescue Therapy after Corticosteroid Failure
par: Sebastian Voicu, et autres
Publié: (2021) -
Rapid successful management of diffuse alveolar hemorrhage as the primary presentation of chlorine gas inhalation; A rare case report
par: samaneh kakhki, et autres
Publié: (2021) -
Acute Respiratory Distress Syndrome: Focus on Viral Origin and Role of Pulmonary Lymphatics
par: Eleonore Fröhlich
Publié: (2021) -
Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS)
par: Seyed MohammadReza Hashemian, et autres
Publié: (2021)